Decreasing chronic graft-versus-host disease rates in all populations
Paul A. Carpenter(Fred Hutch Cancer Center), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), Albert C. Yeh(University of Washington), Rachel B. Salit(Johns Hopkins Hospital), Ann Dahlberg(Seattle Children's Hospital), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Lauri Burroughs(University of Washington), Effie W. Petersdorf(University of Washington), Julie R. Boiko(University of Washington Medical Center), Corinne Summers(Seattle Children's Hospital), Elizabeth F. Krakow(Fred Hutch Cancer Center), Phuong Vo(University of Washington Medical Center), Catherine J. Lee(University of Utah), Masumi Ueda(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Laura Connelly‐Smith(University of Washington Medical Center)
Cited by 23
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409